Publication date: October 2026 Source: American Journal of Obstetrics and Gynecology, Volume 235, Issue 4 Author(s): Koji Matsuo, Matthew W. Lee, Emmeline L. Friedman, Hadi Erfani, Alexia J. Ouzounian, Shinya Matsuzaki, Lynda D. Roman
Survival assessment of adjuvant chemotherapy for cytology-negative, non-myoinvasive stage IC clear cell endometrial cancer. // American Journal of Obstetrics & Gynecology. – URL: https://www.sciencedirect.com/science/article/pii/S000293782600325X?dgcid=rss_sd_all
Survival assessment of adjuvant chemotherapy for cytology-negative, non-myoinvasive stage IC clear cell endometrial cancer. American Journal of Obstetrics & Gynecology. https://www.sciencedirect.com/science/article/pii/S000293782600325X?dgcid=rss_sd_all
“Survival assessment of adjuvant chemotherapy for cytology-negative, non-myoinvasive stage IC clear cell endometrial cancer.” American Journal of Obstetrics & Gynecology.
@article{article116376,
title = {Survival assessment of adjuvant chemotherapy for cytology-negative, non-myoinvasive stage IC clear cell endometrial cancer},
journal = {American Journal of Obstetrics \& Gynecology},
url = {https://www.sciencedirect.com/science/article/pii/S000293782600325X?dgcid=rss_sd_all}
}